Abstract
Borneol is a bicyclic monoterpene that has long been used in traditional Chinese medicine to increase blood–brain barrier permeability and has shown promising cardiovascular effects. The present study aimed to evaluate the effect of borneol on vascular tone, blood pressure, autonomic function, and baroreflex sensitivity in normotensive and hypertensive rats. A combination of in vitro and in vivo assays was performed in 2-kidneys-1-clip hypertensive rats (2K1C) and their controls (sham). We assessed the in vivo effect of oral treatment with borneol on blood pressure, heart rate, autonomic function, and baroreflex sensitivity in sham and 2K1C rats. Additionally, the vasorelaxant effect of borneol in the superior mesenteric artery isolated from rats and its mechanism of action were evaluated. Oral administration of borneol (125 mg/kg/day) reduced blood pressure, sympathetic vasomotor hyperactivity, and serum oxidative stress and improved baroreflex sensitivity in 2K1C rats. In vessel preparations, borneol induced endothelium-independent vasodilatation after precontraction with phenylephrine or KCl (60 mM). There was no difference in the vascular effect induced by borneol in either the 2K1C or the sham group. In addition, borneol antagonized the contractions induced by CaCl2 and reversed (S)-(−)-Bay K 8644-induced contraction. These data suggest that borneol presents antihypertensive effects in 2K1C rats, which is associated with its ability to improve autonomic impairment and baroreflex dysfunction. The borneol-induced relaxation in the superior mesenteric artery involves L-type Ca2+ channel blockade. This vascular action associated with the antioxidant effect induced by borneol may be responsible, at least in part, for the in vivo effects induced by this monoterpene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Noubiap JJ, Nansseu JR, Nyaga UF, Sime PS, Francis I, Bigna JJ. Global prevalence of resistant hypertension: a meta-analysis of data from 32 million patients. Heart. 2019;105:98–105. https://doi.org/10.1136/heartjnl-2018-313599.
Nabavi SM, Šamec D, Tomczyk M, Milella L, Russo D, Habtemariam S. et al. Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering. Biotechnol Adv. 2018;18:1–12. https://doi.org/10.1016/j.biotechadv.2018.11.005.
Tabanca N, Kirimer N, Demirci B, Demirci F, Baser KH. Composition and antimicrobial activity of the essential oils of Micromeria cristata subsp. Phrygia and the enantiomeric distribution of borneol. J Agric Food Chem. 2001;49:4300–3.
Tabanca N, Demirci B, Baser KH, Aytac Z, Ekici M, Khan SI, et al. Chemical composition and antifungal activity of Salvia macrochlamys and Salvia recognita essential oils. J Agric Food Chem. 2006;54:6593–7.
Svoboda, KP, Hampson, JB. Bioactivity of essential oils of selected temperate aromatic plants: antibacterial, antioxidant, antiinflammatory and other related pharmacological activities. In: Speciality chemicals for the 21st century, ADEME/IENICA. 1999; pp. 1–17. Available from http://ienica.csl.gov.uk/specchemseminar/svoboda.pdf.
Silva-Filho JC, Oliveira NNPM, Arcanjo DDR, Quintans-Júnior LJ, Cavalcanti SCH, Santos MRV, et al. Investigation of mechanisms involved in (−)-Borneol-induced vasorelaxant response on rat thoracic aorta. Basic Clin Pharmacol Toxicol. 2011;110:171–7.
Santos SE, Ribeiro FPRA, Menezes P,MN, Duarte-Filho LAM, Quintans JSS, Quintans-Junior LJ. et al. New insights on relaxant effects of (−)-borneol monoterpene in rat aortic rings. Fundam Clin Pharm. 2019;33:148–58. https://doi.org/10.1111/fcp.12417.
Kumar MS, Kumar S, Raja B. Antihypertensive and antioxidant potential of borneol-A natural terpene in L-NAME – Induced hypertensive rats. Int J Pharm Biol Arch. 2010;1:271–9.
Braga VA, Medeiros IA, Ribeiro TP, França-Silva MS, Botelho-Ono MS, Guimarães DD. Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension. Braz J Med Biol Res Line. 2011;44:871–6. https://doi.org/10.1590/S0100-879X2011007500088.
Braga VA. Depressed baroreflex sensitivity in hypertensive rats: a role for reactive oxygen species. J Hypertens. 2012;1:103. https://doi.org/10.4172/2167-1095.1000e103.
Hirooka Y, Kishi T, Sakai K, Takeshita A, Sunagawa K. Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension. Am J Physiol Regul Integr Comp Physiol. 2011;300:818–26. https://doi.org/10.1152/ajpregu.00426.2010.
Oliveira-Sales EB, Toward MA, Campos RR, Paton JF. Revealing the role of the autonomic nervous system in the development and maintenance of Goldblatt hypertension in rats. AutonNeurosci. 2014;183:23–29. https://doi.org/10.1016/j.autneu.2014.02.001.
Campos RR, Oliveira-Sales EB, Nishi EE, Paton JF, Bergamaschi CT. Mechanisms of renal sympathetic activation in renovascular hypertension. Exp Physiol. 2015;100:496–501. https://doi.org/10.1113/expphysiol.2014.079855.
Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension. 1991;17:707–719. https://doi.org/10.1161/01.hyp.17.5.707.
Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension. The production of persistent elevation systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347–78. https://doi.org/10.1084/jem.59.3.347.
Chen JY, Huang XT, Wang JJ, Chen Y. In vivo effect of borneol on rat hepatic CYP2B expression and activity. Chem Biol Interact. 2017;5:96–102. https://doi.org/10.1016/j.cbi.2016.11.024. 261.
Queiroz TM, Guimarães DD, Mendes-Junior LG, Braga VA. a-lipoic acid reduces hypertension and increases baroreflex sensitivity in renovascular hypertensive rats. Molecules. 2012;17:13357–67. https://doi.org/10.3390/molecules171113357.
Tanaka Y, Mochizuki Y, Shigenobu K. Significant role of neuronal non-N-type calcium channels in the sympathetic neurogenic contraction of rat mesenteric. Br J Pharmacol. 1999;128:1602–8. https://doi.org/10.1038/sj.bjp.0702954.
Cavalcanti CO, Alves RR, De Oliveira AL, Cruz JC, De França-Silva MS, Braga VA. et al. Inhibition of PDE5 restores depressed baroreflex sensitivity in renovascular hypertensive rats. Front Physiol. 2016;7:15. https://doi.org/10.3389/fphys.2016.00015.
Carvalho-Galvão A, Ogunlade B, Xu J, Silva-Alves CRA, Mendes-Júnior LG, Guimarães DD. et al. Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats. Clin Sci. 2018;132:1513–27. https://doi.org/10.1042/CS20180222.
Cerutti C, Gustin MP, Paultre CZ, Lo M, Julien C, Vincent M. Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach. Am J Physiol. 1991;261:1292–1299. https://doi.org/10.1152/ajpheart.1991.261.4.H1292.
Mendes-Júnior LG, Guimarães DD, Gadelha DDA, Diniz TF, Brandão MCR, Athayde-Filho PF. et al. The new nitric oxide donor cyclohexane nitrate induces vasorelaxation, hypotension, and antihypertensive effects via NO/cGMP/PKG pathway. Front Physiol. 2015;243:1–9. https://doi.org/10.3389/fphys.2015.00243.
Li P, Huang P-P, Yang Y, Liu C, Lu Y, Wang F. et al. Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats. J Appl Physiol. 2017;122:121–9. https://doi.org/10.1152/japplphysiol.01019.2015.
Botelho-Ono MS, Pina HV, Sousa KHF, Nunes FC, Medeiros IA, Braga VA. Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats. Auton Neurosci. 2011;159:38–44. https://doi.org/10.1016/j.autneu.2010.07.025.
Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT. et al. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens. 2009;22:484–92. https://doi.org/10.1038/ajh.2009.17.
Navar LG, Zou L, Thun AV, Wang CT, Imig JD, Mitchell KD. Unraveling the mystery of goldblatt hypertension. N. Physiol Sci. 1998;13:170–76. https://doi.org/10.1152/physiologyonline.1998.13.4.170.
Lucera GM, Menani JV, Colombari E, Colombari DSA. ANG II and aldosterone acting centrally participate in the enhanced sodium intake in water-deprived renovascular hypertensive rats. Front Pharm. 2021;12:1–10. https://doi.org/10.3389/fphar.2021.679985.
Cabral AM, Vasquez EG. Time course of cardiac sympathetic and vagal tone changes in renovascular hypertensive rats. Am J Hypertension. 1991;4:815–9. https://doi.org/10.1093/ajh/4.10.815.
Oliveira-Sales EB, Colombari E, Abdala AP, Campos RR, Paton JFR. Sympathetic overactivity occurs before hypertension in the two-kidney, one-clip model. Exp Physiol. 2016;101:67–80. https://doi.org/10.1113/EP085390.
Oliveira-Sales EB, Toward MA, Campos RR, Paton JFR. Revealing the role of the autonomic nervous system in the development and maintenance of Goldblatt hypertension in rats. Autonomic Neurosci: Basic Clin. 2014;183:23–29. https://doi.org/10.1016/j.autneu.2014.02.001.
Liu R, Zhang L, Lan X, Li L, Zhang TT, Sun JH. et al. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway. Neuroscience. 2011;176:408–19. https://doi.org/10.1016/j.neuroscience.2010.11.029.
Nishi EE, Bergamaschi CT, Oliveira-Sales EB, Simon KA, Campos RR. Losartan reduces oxidative stress within the rostral ventrolateral medulla of rats with renovascular hypertension. Am J Hypertens. 2013;26:858–65. https://doi.org/10.1093/ajh/hpt037.
Faber JE, Brody MJ. Neural contribution to renal hypertension following acute renal artery stenosis in conscious rats. Hypertension. 1983;5:155–64. https://doi.org/10.1161/01.hyp.5.2_pt_2.i155.
Saavedra JM. Brain angiotensin II: new developments, un- answered questions and therapeutic opportunities. Cell Mol Neurobiol. 2005;25:485–512. https://doi.org/10.1007/s10571-005-4011-5.
Hirooka Y, Kishi T, Sakai K, Takeshita A, Sunagawa K. Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension. Am J Physiol Regul Integr Comp Physiol. 2011;300:R818–R826. https://doi.org/10.1152/ajpregu.00426.2010.
Senoner T, Dichtl W. Oxidative stress in cardiovascular diseases: Still a therapeutic target? Nutrients. 2019;11:1–25. https://doi.org/10.3390/nu11092090.
Zygmunt PM, Ryman T, Hogestatt ED. Regional differences in endothelium-dependent relaxation in the rat: contribution of nitric oxide and nitric oxide-independent mechanisms. Acta Physiol Scand. 1995;155:257–66. https://doi.org/10.1111/j.1748-1716.1995.tb09972.x.
O’brien SF, Mckendrick JD, Radomski MW, Davidge ST, Russell JC. Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance. Can J Physiol Pharmacol. 1998;76:72–6.
Folkow B. Physiological aspects of primary hypertension. Physiological Rev. 1982;62:347. https://doi.org/10.1152/physrev.1982.62.2.347.
Zhang, QL; Fu, BM; Zhang, ZJ. Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability. Drug Deliv. 2017;24:1037–44. https://doi.org/10.1080/10717544.2017.1346002.
Zheng Q, Chen ZX, Xu MB, Zhou XL, Huang YY, Zheng GQ. et al. Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood-brain barrier permeability: a preclinical systematic review and meta-analysis. Drug Deliv. 2018;25:1617–33. https://doi.org/10.1080/10717544.2018.1486471.
Wu JY, Li YJ, Yang L, Hu YY, Hu XB, Tang TT. et al. Borneol and Α-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors. Drug Deliv. 2018;25:1858–64. https://doi.org/10.1080/10717544.2018.1516005.
Hou T, Li X, Peng C. Borneol enhances the antidepressant effects of asiaticoside by promoting its distribution into the brain. Neurosci Lett. 2017;12:56–61. https://doi.org/10.1016/j.neulet.2017.02.068. 646.
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2007;22:659–61. https://doi.org/10.1096/fj.07-9574LSF.
Acknowledgements
We are grateful to Clênia Cavalcante, Matheus Monteiro, and Sara Alves for the technical assistance during the execution of this work.
Funding
This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brazil (CAPES) – Finance Code 001; and Universidade Federal da Paraíba and Paraíba State Research Foundation (FAPESQ, ID: 007/2019 FAPESQ-PB-MCT/CNPq).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Luz, M.S., Gadelha, D.D.A., Andrade, K.J.S. et al. Borneol reduces sympathetic vasomotor hyperactivity and restores depressed baroreflex sensitivity in rats with renovascular hypertension. Hypertens Res 45, 802–813 (2022). https://doi.org/10.1038/s41440-022-00868-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-022-00868-6